絞り込み

16636

広告

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial.

著者 Matthews DR , Paldánius PM , Proot P , Chiang Y , Stumvoll M , Del Prato S ,
Lancet.2019 Sep 17 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (24view , 0users)

Full Text Sources

Early treatment intensification leading to sustained good glycaemic control is essential to delay diabetic complications. Although initial combination therapy has been suggested to offer more opportunities than a traditional stepwise approach, its validity remains to be determined.
PMID: 31542292 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード